Thiamine tetrahydrofurfuryl disulfide: A little known therapeutic agent

Medical Science Monitor

Volumn 10, Issue 9, 2004, Pages

  Lonsdale, Derrick ^a,b  

^a Preventive Medicine Group   (United States)

^b NONE   (United States)

Author keywords

Neurological disease; Thiamine disulfide

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; COCARBOXYLASE; FURSULTIAMINE; NATURAL PRODUCT; PYRUVATE DEHYDROGENASE; THIAMINE; THIAMINE ALLYL DISULFIDE; THIAMINE DERIVATIVE; THIAMINE TRIPHOSPHATE; TRANSKETOLASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTISM; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISULFIDE BOND; DOWN SYNDROME; DRUG SYNTHESIS; ENERGY METABOLISM; EVOKED BRAIN STEM AUDITORY RESPONSE; GARLIC; HUMAN; LEIGH DISEASE; MENTAL DETERIORATION; MUSCLE STRENGTH; NEUROLOGIC DISEASE; NONHUMAN; PARALYTIC ILEUS; POSTOPERATIVE COMPLICATION; REVIEW; SOLUBILITY; SUDDEN INFANT DEATH SYNDROME; THIAMINE DEFICIENCY; VITAMIN METABOLISM;

DISULFIDES; FURSULTIAMIN; GARLIC; HUMANS; JAPAN; THIAMINE;

EID: 4644371377     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Lonsdale D: Thiamine metabolism in disease. CRC Crit Rev Lab Sci, 19:289-313
2. Baker H, Frank O. Absorption, utilization and clinical effectiveness of allithiamines compared to water-soluble thiamines. J Nutr Sci Vitaminol, 1976; 22(Suppl): 63-68
3. Lonsdale D: Thiamine and its fat-soluble derivatives as therapeutic agents. Int Clin Nutr Rev, 1987; 7; 114-25
4. Lonsdale D: Clinical use of water-soluble thiamine and its fat-soluble derivative, thiamine tetrahydrofurfuryl disulfide (TTFD). Int J Biosocial Research, 1987; 9(2): 144-52
5. Lonsdale D; Allithiamine and its synthetic derivatives: a review. J Nutr Med, 1991; 2: 305-11
6. Shimazono N, Katsura E, eds. Beriberi and Thiamine. Tokyo, Igaku Shoin Ltd., 1965; 1-295
7. Platt BS: Thiamine deficiency in human beriberi and in Wernicke's encephalopathy. In: Wolstenholme GEW, O'Connor M, eds. Thiamine Deficiency: Biochemical Lesions and their Clinical Significance. Boston, Little, Brown and Company 1967; 136
8. Cooper JR, Pincus JH: The role of thiamine in nervous tissue. Neurochem Res, 1979; 4: 223-39
9. Kanno M: Effect of thiamine alkyl disulfide on the isolated guiea pig atrium. Arch Int Pharmacodyn, 1965; 157; 280-88
10. Shinozaki H: Cardiac action of thiamine derivatives in guinea pig atria. J Nutr Sci Vitaminol, 1976; 22: 29-34
11. Tohse H, Hauzen H, Kanno M: Inhibition of the delayed rectifier K current in guinea-pig cardiomyocytes by thiamine tetrahydrofurfuryl disulfide. Naunyn-Schmiedeberg's Arch Pharmacol, 1998; 357: 540-47
12. Hauzen H, Kanno M: Thiamine and its derivatives inhibit delayed rectifier potassium channels of rat cultured cortical neurons. Neuropharmacology, 1998; 37: 313-22
13. Suzuoki-Ziro, Murakami K, Kikuchi S et al: Urinary metabolites of thiamine tetrahydrofurfuryl disulfide in rats. J Pharmacol Exp Ther, 1967: 158: 353-64
14. Lonsdale D: The syndrome of functional dysautonomia. Med Hypoth, 1981; 7: 495-502
15. Lonsdale D: Functional dysautonomia. J Adv Med, 1990; 3: 189-97
16. Lonsdale D: Asymmetric functional dysautonomia. J Nutr Med, 1990; 1: 59-61
17. Williams RD, Mason HL, Power MH, Wilder RM: Induced thiamine (Vitamin BI) deficiency in man; relation of depletion of thiamine to development of biochemical defect and of polyneuropathy. Arch Int Med, 1943; 71: 38-53
18. Lonsdale D, Shamberger RJ: Red cell transketolase as an indicator of nutritional deficiency. Am J Clin Nutr, 1980; 33: 205-11
19. Lonsdale D: Red cell transketolase studies in a private practice specializing in nutritional correction. J Am Coll Nutr, 1988; 7: 61-67
20. Tan GH, Farnell GF, Hensrud DD, Lutin SC: Acute Wernicke's encephalopathy attributable to pure dietary thiamine deficiency. Mayo Clin Proc, 1994; 69: 849-50
21. Lonsdale D: Hypothesis and case reports: possible thiamine deficiency. J Am Coll Nutr, 1990; 9: 13-17
22. Williams RR, Cline JK: Synthesis of vitamin B1; J Am Chem Soc, 1936; 58: 1504-6
23. Peters RA: The biochemical lesion in vitamin B1 deficiency. Lancet, 1936; 1: 1161-65
24. Zbinden G: Therapeutic use of vitamin B1 in diseases other than beriberi. Ann N Y Acad Sci, 1962; 98: 550-61
25. Pauling L: Orthomolecular psychiatry. Science, 1968; 160: 265-71
26. Pauling L: Orthomolecular somatic and psychiatric medicine. J Diseases of Civilization, 1968: 12: 1-3
27. Meador KJ, Nichols ME, Franke P et al: Evidence for a central cholinergic effect of high-dose thiamine. Ann Neurol, 1993; 34; 724-26
28. Meador K, Loring D, Nichols M et al: Preliminary findings of high-dose thiamine in Alzheimer's type. J Geriat Psychiat Neurol, 1993; 6: 222-29
29. Gibson GE, Zhang H: Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochemistry International, 2002; 40: 493-504
30. Lonsdale D, Faulkner WR, Price JW et al: Intermittent cerebellar ataxia associated with hyperpyruvic acidemia, hyperalaninemia and hyperalaninuria. Pediat, 1969; 43: 1025-34
31. Blass JP, Lonsdale D, Uhlendorf BW et al: Intermittent ataxia with pyravate decarboxylase deficiency. Lancet, 1971; 1: 1302
32. Bitsch R, Wolf M, Moller J et al: Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative. Ann Nutr Metab, 1991; 35: 292-96
33. Fujiwara M, Watanabe H, Matsui K: Allithiamine, a newly found derivative of vitamin B1. J Biochem, 1954; 41: 29-39
34. Fujita T, Suzuoki Z: Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. I. Microsomal S-transmethylase. J Biochem, 1973; 74: 717-22
35. Fujita T, Suzuoki Z, Kozuka S, Oae S: Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. II. Sulfide and sulfoxide oxygenases in microsomes. J Biochem, 1973; 74: 723-32
36. Fujita T, Suzuoki Z: Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. III. Oxidative cleavage of the tetrahydrofuran moiety. J Biochem, 1973; 74: 733-38
37. Fujita T, Teraoka A, Suzuoki Z: Enzymatic studies on the metabolism of the tetrahydrofurfuryl mercaptan moiety of thiamine tetrahydrofurfuryl disulfide. IV. Induction of microsomal S-transmethylase and sulfide and sulfoxide oxygenases in the drug-treated rat. J Biochem, 1973; 74: 739-45
38. Mitoma C: Metabolic disposition of thiamine tetrahydrofurfuryl disulfide in dog and man. Drug Metabol Disposition, 1973; 1: 698-703
39. Erikson S, Guthenberg C: The identity of enzymes reducing a thiamine disulfide derivative and cystine derivatives via thiol-dusulfide exchange. Biochem Pharmacol, 1975; 24: 241-47
40. Lonsdale D: Effect of thiamine tetrahydrofurfuryl disulfide on audiogenic seizures in DBA/J2 mice. Dev Pharmacol Ther, 1982; 4: 28-36
41. Hukuhara T, Fukuda H: The effects of thiamine tetrahydrofururyl disulfide upon the movement of the isolated small intestine. J Vitaminol, 1965; 11: 253-60
42. Ogawa K, Hirano H, Shinozaki H: Ultracytochemical studies on the effects of thiamine and thiamine tetrahydrofurfuryl disulfide on acetylcholinesterase activity in guinea pig atria. J Nutr Sci Vitaminol (Tokyo), 1976; 22: 71-78
43. Mizutani M, Ihara T, Kaziwara K: Effects of orally administered thiamine tetrahydrofurfuryl disulfide on foetal development of rabbits and monkeys. Japan J Pharmacol, 1972; 22: 115-24
44. Mitzushima Y: Anti-inflammatory effect of thiamine derivatives. Vitamins (Japan), 1967; 36: 305-10
45. Ohta T, Ishigaki K: Evaluation of large dose therapy with an active type thiamine (TTFD) in diabetic neuropathy. Shinryo, 1963; 16: 100-9
46. Shimura H, Katsuno K, Kitnura T, Watanabe T: Studies of parenteral Alinamin-F odorless in massive doses in postoperative intestinal paralysis. Rinsho to Kenkyu, 1962; 39: 127-36
47. Nishiyama I, Tanaka T, Tsumura D: Effect of thiamine tetrahydrofurfuryl disulfide (TTFD) on physical fitness chiefly in muscle strength: double blind studies. J Physical Fitness Japan, 1972; 21: 5-15
48. Mimori Y, Katsuoka H, Nakamura S: Thiamine therapy in Alzheimer's disease Metab Brain Dis, 1996; 11: 89-94
49. Lonsdale D, Nodar R H, Orlowski JP: Brainstem dysfunction in infants responsive to thiamine disulfide: preliminary studies in four patients. Clin EEG, 1982; 13: 82-88
50. Jeffrey HE, McCleary BV, Hensley WJ, Read DJC: Thiamine deficiency-a neglected problem of infants and mothers- possible relationship to sudden infant death syndrome. Aust NZ J Obst Gynaecol, 1985; 25: 198-202
51. Lonsdale D: Treatment of threatened SIDS with megadose thiamine hydrochloride. Pediat Res, 1977; 11: 379 (Abst)
52. Davis RE, Icke GC, Hilton JMN: High thiamine levels in sudden infant death syndrome N Engl J Med, 1980; 303; 462
53. Lonsdale D: Sudden infant death syndrome requires genetic predisposition, some form of stress and marginal malnutrition. Med Hypoth, 2001; 57(3): 382-86
54. Pincus JH, Cooper JR, Itokawa Y et al: Subacute necrotizing encephalomyelopathy: effects of thiamine and thiamine propyl disulnde. Arch Neurol, 1971; 24: 511-17
55. Pincus JH, Cooper JR, Murphy JV et al: Thiamine derivatives in subacute necrotizing encephalomyelopathy. Pediat, 1973; 51: 716-21
56. Lonsdale D, Kissling CD: Clinical trials with thiamine tetrahydrofurfuryl disulfide in Down's syndrome. J Orthomol Med, 1986; 1: 169-75
57. Lonsdale D, Shamberger RJ, Audhya T: Treatment of autistic spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuroendocrinol Lett, 2002; 23: 303-8
58. Kidd PM: Autism, an extreme challenge to integrative medicine, Part II: medical management. Alt Med Rev, 2002; 7: 472-99
59. Kim JK, Miller VS, Cauller PR et al: Effectiveness of N, N-dimethylglycine in autism and pervasive developmental disorder. J Child Neurol, 2001; 16: 169-73
60. Messahel S, Pheasant AE, Pall H et al: Urinary levels of neopterin and biopterin in autism. Neurosci Lett, 1998; 241: 17-20
61. Page T: Metabolic approaches to the treatment of autism spectrum disorders. J Autism Dev Disord, 2000; 30: 463-69
62. Rimland B, McGinnis W: Vaccines and autism. Lab Med, 2002; 33: 708-16
63. Bratton GR, Zmudzki J, Bell MC, Warnock LG: Thiamine (vitamin B1) effects of lead intoxication and deposition in tissues: therapeutic potential. Toxicol Appl Pharmacol, 1981; 59: 164-72
64. Olkowski AA, Gooneratne SR, Christenson DA: The effects of thiamine and EDTA on biliary and urinary lead excretion in sheep. Toxicol Lett, 1991; 59: 153-59
65. Coppock RW, Wagner WC, Reynolds JD et al: Evaluation of edetate and thiamine for treatment of experimentally induced environmental lead poisoning in cattle. Am J Vet Res, 1991; 52: 1860-64